Purpose

We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.

Condition

Eligibility

Eligible Ages
Between 15 Years and 21 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adolescent patients seen in the Emergency Department who test positive for gonorrhea, chlamydia, or pelvic inflammatory disease and are prescribed outpatient antibiotic treatment.

Exclusion Criteria

  • Patients will be excluded if they are unable to understand English, are critically ill, have cognitive impairment or if they do not have access to a cellular telephone with text messaging capabilities.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Other
mHealth
Adolescents enrolled in this arm will receive treatment-related text messages.
  • Behavioral: mHealth Intervention
    Adolescents will receive text messages to facilitate treatment adherence
No Intervention
Usual care
Adolescents in this arm will receive usual care.

Recruiting Locations

Children's National and nearby locations

Children's National Hospital
Washington, District of Columbia 20016-1838
Contact:
Monika Goyal
202-476-2869
mgoyal@cnmc.org

More Details

NCT ID
NCT04372485
Status
Recruiting
Sponsor
Children's National Research Institute

Study Contact

Meleah Boyle, MPH
202-476-5388
mdboyle@childrensnational.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.